Precision Sleep Medicine
1 other identifier
observational
1,055
1 country
2
Brief Summary
This retrospective observational study aims to characterize the prevalence and clinical features of obstructive sleep apnea (OSA) phenotypes and develop a rater-independent algorithm for automated OSA phenotyping, improving diagnosis and personalized treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedFirst Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
March 30, 2025
CompletedMarch 30, 2025
March 1, 2025
2.6 years
March 24, 2025
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phenotype characterization
To characterize the prevalence and clinical features of distinct obstructive sleep apnea (OSA) phenotypes in a large, diverse patient population, polysomnography (PSG) recordings from two publicly available National Sleep Research Resource data collections are analyzed and compared to datasets from the University Hospital Basel (USB) and University Children's Hospital Basel (UKBB) to assess generalizability.
2025
Secondary Outcomes (1)
Computer-aided phenotyping
2025
Study Arms (2)
Adults
Adults who underwent polysomnography recordings at the University Hospital Basel in 2023.
Children and adolescents
Children and adolescents who underwent polysomnography recordings at the University Children's Hospital Basel between January 2022 to July 2024.
Eligibility Criteria
Adults who underwent polysomnography recordings at the University Hospital Basel in 2023, as well as children and adolescents who underwent polysomnography recordings at the University Children's Hospital Basel between January 2022 and July 2024. All patients have signed the general consent of the university hospital (UBS), resp. The university children's hospital (UKBB).
You may qualify if:
- age 19 years and older (data from University Hospital Basel (USB))
- age 18 years or younger (data from University Children's Hospital Basel (UKBB))
- Epworth Sleepiness Scale (ESS) score available (USB only)
- Diagnosis available (e.g. Obstructive sleep apnea (OSA), Central Sleep Apnea (CSA), Cheyne Stokes Breathing (CSR), ...)
- signed written general consent
You may not qualify if:
- history of treatment of sleep apnea
- tracheostomy
- current home oxygen therapy
- decline to sign the written general consent, or absence of written general consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- Rekonas GmbHcollaborator
Study Sites (2)
University Children's Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Herrmann, Dr. med.
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2025
First Posted
March 30, 2025
Study Start
January 1, 2022
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
March 30, 2025
Record last verified: 2025-03